Germany Pharma & API Export Playbook
How Indian API and pharma manufacturers qualify for German and EU buyers — buyer types, EU-GMP/CEP compliance and competitor landscape.
HS codes: 2941 (antibiotics), 2933/2934 (heterocyclics), 3003/3004 (medicaments)
Market size
Germany is Europe's largest pharma market; the EU imports large volumes of APIs and intermediates. Supply-chain diversification (beyond China) is a policy priority.
Import trends
China+1 sourcing for APIs, demand for EU-GMP-certified suppliers with documented quality. Generics and intermediates buyers actively qualifying Indian plants.
Buyer categories
- ✓Generic drug manufacturers
- ✓API importers & distributors
- ✓Contract manufacturers (CDMO)
- ✓Wholesalers & procurement groups
- ✓EU sourcing agents
Required certifications
- ✓EU-GMP certification
- ✓CEP / EDMF (DMF) filings
- ✓Written Confirmation (WC)
- ✓ISO 9001 / ICH Q7
- ✓Stability & impurity data
- ✓Pharmacovigilance readiness
Pricing strategy
Price to landed cost incl. regulatory overhead; buyers pay for EU-GMP compliance, documentation and reliability. Expect audits and DMF review before supply. Quote in EUR, hold stability.
Distribution channels
- ✓Direct manufacturer/CDMO supply after qualification
- ✓API distributor channels
- ✓EU wholesaler networks
- ✓Long-term supply agreements
- ✓Trade-fair discovery (CPHI)
Compliance requirements
EU-GMP + Written Confirmation mandatory; CEP/DMF filings required; strict pharmacovigilance and quality documentation. Compliance flagged for your regulatory & legal teams.
Competitor landscape
Competition from China (scale/price) and established EU-GMP Indian majors. Differentiators: EU-GMP-certified plants, documentation depth, China+1 positioning.
Ready to act on this market?
We'll research and verify real buyers in Germany, score them for fit, and run compliant outreach with your approval at every gate.
Figures are indicative and not legal, tax or investment advice.